Found: 13
Select item for more details and to access through your institution.
Remote Monitoring in the Home Validates Clinical Gait Measures for Multiple Sclerosis.
- Published in:
- Frontiers in Neurology, 2018, p. 1, doi. 10.3389/fneur.2018.00561
- By:
- Publication type:
- Article
Neurofilaments: neurobiological foundations for biomarker applications.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Toward the end of a controversy on the effect of reduction in brain amyloid levels on change in cognitive and functional decline in Alzheimer's disease—Reply to a letter.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 3, p. 1101, doi. 10.1002/alz.12864
- By:
- Publication type:
- Article
Effect of reduction in brain amyloid levels on change in cognitive and functional decline in randomized clinical trials: An instrumental variable meta‐analysis.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 4, p. 1292, doi. 10.1002/alz.12768
- By:
- Publication type:
- Article
A randomized study of natalizumab dosing regimens for relapsing–remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2240, doi. 10.1177/13524585211003020
- By:
- Publication type:
- Article
Slowly expanding lesions are a marker of progressive MS – No.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 11, p. 1681, doi. 10.1177/13524585211017020
- By:
- Publication type:
- Article
Towards the incorporation of lumbar puncture into clinical trials for multiple sclerosis.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Serum Neurofilament Light and Multiple Sclerosis Progression Independent of Acute Inflammation.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 2, p. e2147588, doi. 10.1001/jamanetworkopen.2021.47588
- By:
- Publication type:
- Article
Safety, Patient-Reported Well-Being, and Physician-Reported Assessment of Walking Ability in Patients with Multiple Sclerosis for Prolonged-Release Fampridine Treatment in Routine Clinical Practice: Results of the LIBERATE Study.
- Published in:
- CNS Drugs, 2021, v. 35, n. 9, p. 1009, doi. 10.1007/s40263-021-00840-x
- By:
- Publication type:
- Article
Inflammatory Activity on Natalizumab Predicts Short-Term but Not Long-Term Disability in Multiple Sclerosis.
- Published in:
- PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0169546
- By:
- Publication type:
- Article
Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 9, p. 1070, doi. 10.1177/13524585231176732
- By:
- Publication type:
- Article
Genome-wide study of longitudinal brain imaging measures of multiple sclerosis progression across six clinical trials.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41099-0
- By:
- Publication type:
- Article
New views on the complex interplay between degeneration and autoimmunity in multiple sclerosis.
- Published in:
- Frontiers in Cellular Neuroscience, 2024, p. 1, doi. 10.3389/fncel.2024.1426231
- By:
- Publication type:
- Article